TrialInternational journal of environmental research and public health2021

Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017-2018.

Zayniddin Sayfutdinov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.